Parenteral Drugs Market Size, Trends, Growth & Outlook

Parenteral Drugs Market - By Product Type (Cytokines, Insulin, Peptide Antibiotics, Monoclonal Antibodies, Peptide Hormones, Small Molecule Antibiotics, Others), By Route of Administration (Intravenous, Intramuscular, Subcutaneous), By Molecule Type (T Small Molecule, Large Molecule), By Application (Diabetes, Pain Management, Infectious Diseases, CNS Diseases, Cardiovascular Diseases, Others), By Distribution Channel (Hospital Pharmacies, Drug Stores, Online Pharmacies, Retail Pharmacies) & Global Region - Market Size, Trends, Opportunity, Forecast 2019-2027

Industry: Life Science | Report ID: FAMI-00755 | Published on: Feb, 2020 | View: 98 | Share:         

Request Sample Enquire Before Buying Request Discount

  • Report Descripton
  • Table Of Content
  • Request Methodology
  • Request Customization

This study aims to provide a detailed analysis of the global parenteral drugs market along with qualitative trends for the year 2019. Further, the report also offers future trends and market forecast upto 2027.

The study includes the parenteral drugs market size and forecast for the global parenteral drugs market through 2027, segmented by product type, molecule type, route of administration, application, distribution channel and region type as follows:

Parenteral Drugs Market, By Product Type:
• Cytokines
• Insulin
• Monoclonal Antibodies
• Peptide Antibiotics
• Vaccines
• Immunoglobulin
• Peptide Hormones
• Blood Factors
• Small Molecule Antibiotics
• Chemotherapy Agents
• Others

Parenteral Drugs Market, By Route of Administration:
• Intravenous (IV)
• Intramuscular (IM)
• Subcutaneous (SC)

Parenteral Drugs Market, By Molecule Type:
• T Small Molecule
• Large Molecule

Parenteral Drugs Market, By Application:
• Diabetes
• Blood Disorders
• Musculoskeletal Disorders
• CNS Diseases
• Pain Management
• Oncology
• Infectious Diseases
• Hormonal Disorders
• Cardiovascular Diseases

Parenteral Drugs Market, By Distribution Channel:
• Hospital Pharmacies
• Drug Stores
• Retail Pharmacies
• Online Pharmacies

An in-depth analysis of the regional market scenario of the industry offers detailed qualitative and quantitative insights about the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa) along with the coverage of major countries in each region.

Parenteral Drugs Market, By Region:
- North America (U.S. & Canada)
- Europe (Germany, United Kingdom, France, Italy, Spain, Russia and Rest of Europe)
- Asia Pacific (China, India, Japan, South Korea, Indonesia, Taiwan, Australia, New Zealand and Rest of Asia Pacific)
- Latin America (Brazil, Mexico, Argentina and Rest of Latin America)
- Middle East & Africa (GCC, North Africa, South Africa and Rest of Middle East & Africa)

Global parenteral drugs market size has been derived using both primary interviews and secondary research. The research process starts with exhaustive secondary research using internal and external sources to obtain various qualitative and quantitative market insights related to the parenteral drugs market. Also, multiple primary interviews were conducted with industry experts in order to validate data and analysis. Primary interview sources include industry expert such as VPs, Marketing Directors business development managers, market intelligence managers, and country sales managers, and key opinion leaders specializing in the parenteral drugs market.

Some of the features of “Parenteral Drugs Market Report: Market Size, Trends, Opportunity, Forecast 2019-2027” include:

Market Size: Global parenteral drugs market size estimation in terms of value (USD Million)

Forecast Analysis: Market forecast (2019-2027) by application and distribution channel

Segmentation Analysis: Global parenteral drugs market value by various segments such as product type, technology in terms of value

Regional Analysis: Global parenteral drugs market split by North America, Europe, Asia Pacific, Latin America and Middle East & Africa

Growth Opportunities: Analysis on growth opportunities in different segments and regions of parenteral drugs market

Strategic Analysis: This section offers insights on merger and acquisition activities, new product development, and competitive landscape of parenteral drugs in the global parenteral drugs market
Analysis of competitive intensity of the industry on the basis of Porter’s Five Forces model

Key Questions Answered in this Report:

What are the most promising and high-growth trends in the global parenteral drugs market?

What are the key factors impacting market dynamics? What are the growth drivers, and restraints in parenteral drugs market?

What are the emerging industry trends in parenteral drugs market?

What are recent developments in the parenteral drugs market? Which companies are leading these industry activities?

What merger & acquisition activities have occurred in the past 3 years and what is its impact on the parenteral drugs industry?

Get a sample pages of this report Click here

Research Methodology

Market Definition and List of Abbreviations

1. Executive Summary
2. Growth Drivers & Issues in Global Parenteral Drugs Market
3. Global Parenteral Drugs Market Trends
4. Opportunities in Global Parenteral Drugs Market
5. Recent Industry Activities, 2019
6. Porter's Five Forces Analysis
7. Market Value Chain and Supply Chain Analysis
8. Global Parenteral Drugs Market Size (USD Million), Growth Analysis and Forecast, (2019 - 2027)

9. Global Parenteral Drugs Market Segmentation Analysis, By Product Type
9.1. Introduction
9.2. Market Attractiveness, By Product Type
9.3. BPS Analysis, By Product Type
9.4. Cytokines
9.5. Insulin
9.6. Monoclonal Antibodies
9.7. Peptide Antibiotics
9.8. Vaccines
9.9. Immunoglobulin
9.10. Peptide Hormones
9.11. Blood Factors
9.12. Small Molecule Antibiotics
9.13. Chemotherapy Agents
9.14. Others

10. Global Parenteral Drugs Market Segmentation Analysis, By Route of Administration
10.1. Introduction
10.2. Market Attractiveness, By Route of Administration
10.3. BPS Analysis, By Route of Administration
10.4. Intravenous (IV)
10.5. Intramuscular (IM)
10.6. Subcutaneous (SC)

11. Global Parenteral Drugs Market Segmentation Analysis, By Molecule Type
11.1. Introduction
11.2. Market Attractiveness, By Molecule Type
11.3. BPS Analysis, By Molecule Type
11.4. T Small Molecule
11.5. Large Molecule

12. Global Parenteral Drugs Market Segmentation Analysis, By Application
12.1. Introduction
12.2. Market Attractiveness, By Application
12.3. BPS Analysis, By Application
12.4. Diabetes
12.5. Blood Disorders
12.6. Musculoskeletal Disorders
12.7. CNS Diseases
12.8. Pain Management
12.9. Oncology
12.10. Infectious Diseases
12.11. Hormonal Disorders
12.12. Cardiovascular Diseases

13. Global Parenteral Drugs Market Segmentation Analysis, By Distribution Channel
13.1. Introduction
13.2. Market Attractiveness, By Distribution Channel
13.3. BPS Analysis, By Distribution Channel
13.4. Hospital Pharmacies
13.5. Drug Stores
13.6. Retail Pharmacies
13.7. Online Pharmacies

14. Geographical Analysis
14.1. Introduction
14.2. North America Parenteral Drugs Market Size (USD Million), 2019 - 2027
14.2.1. By Product Type
14.2.2. By Route of Administration
14.2.3. By Molecule Type
14.2.4. By Application
14.2.5. By Distribution Channel
14.2.6. By Country
14.2.6.1. Market Attractiveness, By End-user
14.2.6.2. BPS Analysis, By End-User
14.2.6.3. U.S. Market Size (USD Million), 2019 - 2027
14.2.6.4. Canada Market Size (USD Million), 2019 - 2027

14.3. Europe Parenteral Drugs Market Size (USD Million), 2019 - 2027
14.3.1. By Product Type
14.3.2. By Route of Administration
14.3.3. By Molecule Type
14.3.4. By Application
14.3.5. By Distribution Channel
14.3.6. By Country
14.3.6.1. Market Attractiveness, By Country
14.3.6.2. BPS Analysis, By Country
14.3.6.3. Germany Market Size (USD Million), 2019 - 2027
14.3.6.4. United Kingdom Market Size (USD Million), 2019 - 2027
14.3.6.5. France Market Size (USD Million), 2019 - 2027
14.3.6.6. Italy Market Size (USD Million), 2019 - 2027
14.3.6.7. Spain Market Size (USD Million), 2019 - 2027
14.3.6.8. Russia Market Size (USD Million), 2019 - 2027
14.3.6.9. Rest of Europe Market Size (USD Million), 2019 - 2027

14.4. Asia Pacific Parenteral Drugs Market Size (USD Million), 2019 - 2027
14.4.1. By Product Type
14.4.2. By Route of Administration
14.4.3. By Molecule Type
14.4.4. By Application
14.4.5. By Distribution Channel
14.4.6. By Country
14.4.6.1. Market Attractiveness, By Country
14.4.6.2. BPS Analysis, By Country
14.4.6.3. China Market Size (USD Million), 2019 - 2027
14.4.6.4. India Market Size (USD Million), 2019 - 2027
14.4.6.5. Japan Market Size (USD Million), 2019 - 2027
14.4.6.6. South Korea Market Size (USD Million), 2019 - 2027
14.4.6.7. Indonesia Market Size (USD Million), 2019 - 2027
14.4.6.8. Taiwan Market Size (USD Million), 2019 - 2027
14.4.6.9. Australia Market Size (USD Million), 2019 - 2027
14.4.6.10. New Zealand Market Size (USD Million), 2019 - 2027
14.4.6.11. Rest of Asia Pacific Market Size (USD Million), 2019 - 2027

14.5. Latin America Parenteral Drugs Market Size (USD Million), 2019 - 2027
14.5.1. By Product Type
14.5.2. By Route of Administration
14.5.3. By Molecule Type
14.5.4. By Application
14.5.5. By Distribution Channel
14.5.6. By Country
14.5.6.1. Market Attractiveness, By Country
14.5.6.2. BPS Analysis, By Country
14.5.6.3. Brazil Market Size (USD Million), 2019 - 2027
14.5.6.4. Mexico Market Size (USD Million), 2019 - 2027
14.5.6.5. Rest of Latin America Market Size (USD Million), 2019 - 2027

14.6. Middle East & Africa Parenteral Drugs Market Size (USD Million), 2019 - 2027
14.6.1. By Product Type
14.6.2. By Route of Administration
14.6.3. By Molecule Type
14.6.4. By Application
14.6.5. By Distribution Channel
14.6.6. By Country
14.6.6.1. Market Attractiveness, By Geography
14.6.6.2. BPS Analysis, By Geography
14.6.6.3. GCC Market Size (USD Million), 2019 - 2027
14.6.6.4. North Africa Market Size (USD Million), 2019 - 2027
14.6.6.5. South Africa Market Size (USD Million), 2019 - 2027
14.6.6.6. Rest of Middle East & Africa Market Size (USD Million), 2019 - 2027

15. Competitive Landscape
15.1. Novartis AG
15.2. Teva Pharmaceutical Industries
15.3. Pfizer Inc.
15.4. AstraZeneca Plc
15.5. Sun Pharmaceutical Industries
15.6. Mylan N.V
15.7. Cipla Inc.
15.8. Merck & Co., Inc.
15.9. Sanofi S.A.
15.10. Dr. Reddy’s Laboratories Ltd.

Select License Type
  • Single User License $3840 USD
  • Multi-User License $5370 USD
  • Corporate User License $6450 USD

Our Clients

  • +1 518-300-1215Mon-Fri, 24Hrs
  • [email protected]We reply within an hours
  • Albany,
    NY, USA.